Better Buy: Aphria vs. Constellation Brands

If you're an investor interested in profiting from the legal cannabis industry, you know there are many ways to gain exposure to this new, rapidly expanding space in your portfolio. You could buy shares of a cannabis producer like Aphria (NYSE: APHA) or invest in a company that owns a large stake in a pot company, like Constellation Brands (NYSE: STZ), which bought a $4 billion stake in Canopy Growth (NYSE: CGC) in 2018. 

While Constellation Brands may be a relatively safer investment, given that it's primarily in the more stable and mature beer, wine and spirits business, Aphria has shown itself to be less risky than its cannabis-centric peers. It has reported a positive number on adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for three straight quarters. With both companies posting positive results of late, it may not be easy determining which one is the better buy going forward. Let's take a closer look to see which stock has the edge today.

Continue reading

Source Fool.com